阿吉奧動態 ANGO 深 滬
等待開盤 08-22 09:30:00 美东时间
9.07
-0.060
-0.66%
華盛通- 最 高9.19
- 今 開9.04
- 成交量 28.28万股
- 最 低 8.94
- 昨 收 9.13
- 總市值 3.69亿
- 52周最高 13.50
- 市盈率 靜 --
- 換手率 0.70%
- 52周最低 5.83
- 委 比 0.82%
- 總股本 4063.39万
- 歷史最高 32.00
- 量 比 0.82
- 振 幅 2.74%
- 歷史最低 5.26
- 每 手 1
- 風險率 1.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多AngioDynamics Publishes PRESERVE Study Of NanoKnife System For Prostate Tissue Ablation In European Urology
Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment
07-23 20:32
美股大行评级 | 潜在涨幅264.58%！Maxim Group上调SELLAS Life Sciences目标价至7美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持SELLAS Life Sciences Gr"买入"评级，目标价从4美元升至7美元；摩根大通：维持PagSeguro Digital"中性"评级，目标价从12美元升至13美元
07-17 09:07
AngioDynamics Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
07-16 21:11
快讯 | AngioDynamics Inc：Canaccord Genuity将目标价从15美元上调至17美元
AngioDynamics Inc : Canaccord Genuity Raises Target Price to $17 From $15
07-16 12:15
电话会总结 ｜ AngioDynamics(ANGO)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• **财务业绩**： - AngioDynamics (ANGO) 在2025财年第四季度实现总营收为8020万美元，同比增长12.7%。其中，MedTech业务营收为3580万美元，同比增长22%，占总营收的45%；Med Device业务营收为4440万美元，同比增长6.2%。 - 2025财年全年总营收为2.927亿美元，同比增长8.1%。其中，MedTech业务全年营收为1.267亿美元，同比增长19.5%。 - 第四季度毛利率为52.7%，其中MedTech毛利率为59%，Med Device毛利率为47.6%。全年毛利率为53.
07-16 12:11
AngioDynamics projects $305M–$310M FY26 sales as Med Tech drives double-digit growth
Earnings Call Insights: AngioDynamics (ANGO) Q4 2025 Management View James C. Clemmer, CEO, highlighted that "total revenue was $80.2 million representing growth of over 12% year-over-year, led by Med...
07-16 00:42
AngioDynamics shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 revenue guidance above estimates.
AngioDynamics shares are trading higher after the company reported better-than-...
07-15 20:24
AngioDynamics Reports Strong Q4 2025 Financial Results
AngioDynamics ( ($ANGO) ) has shared an announcement. AngioDynamics reported st...
07-15 19:46
AngioDynamics Sees FY2026 Adj EPS $(0.35)-$(0.25) vs $(0.23) Est; Sees Sales $305M-$310M vs $304.858M Est
Fiscal Year 2026 Financial GuidanceGuidance MetricCurrent Guidance(As of July 15, 2025)Tariff Guidance ImpactNet Sales$305 - $310 millionLimited ImpactMed Tech Net Sales Growth12% - 15%Limited ImpactMed Device Net Sales
07-15 18:34
Earnings Scheduled For July 15, 2025
Companies Reporting Before The Bell • Telefonaktiebolaget L M (NASDAQ:ERIC) is ...
07-15 16:32
